With regards to serum tumor marker, six of the seven HCC patients had AFP levels ≥20 ng/mL, whereas all the 11 patients diagnosed with benign nodules had AFP levels <20 ng/mL. This evidence concerns the gene AFP and hepatocellular carcinoma.